UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators

European urology, 2018-12, Vol.74 (6), p.796-804

2018

Volltextzugriff (PDF)

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

European urology, 2019-02, Vol.75 (2), p.310-318

2019

Volltextzugriff (PDF)

Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth

European urology, 2017-07, Vol.72 (1), p.45-51

2017

Volltextzugriff (PDF)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

BJU international, 2020-07, Vol.126 (1), p.124-132

2020

Volltextzugriff (PDF)

External validation of novel magnetic resonance imaging‐based models for prostate cancer prediction

BJU international, 2020-03, Vol.125 (3), p.407-416

2020

Volltextzugriff (PDF)

Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men

World journal of urology, 2021, Vol.39 (1), p.73-80

2021

Volltextzugriff (PDF)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer

BJU international, 2019-10, Vol.124 (4), p.635-642

2019

Volltextzugriff (PDF)

E-bike and classic bicycle-related traumatic brain injuries presenting to the emergency department

Emergency medicine journal : EMJ, 2021-04, Vol.38 (4), p.279-284

2021

Volltextzugriff (PDF)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data

European urology open science (Online), 2022-02, Vol.36, p.1-8

2022

Volltextzugriff (PDF)

Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative

The Journal of urology, 2021-07, Vol.206 (1), p.62-68

2021

Volltextzugriff (PDF)

Age, gender, functional KSS, reason for revision and type of bone defect predict functional outcome 5 years after revision total knee arthroplasty: a multivariable prediction model

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2019-07, Vol.27 (7), p.2289-2296

2019

Volltextzugriff (PDF)

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

Urologic oncology, 2019-02, Vol.37 (2), p.138-144

2019

Volltextzugriff (PDF)

Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

Urologic oncology, 2019-06, Vol.37 (6), p.341-342

2019

Volltextzugriff (PDF)

Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study

Therapeutic advances in urology, 2022-04, Vol.14, p.17562872221090319-17562872221090319

2022

Volltextzugriff (PDF)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome

Translational andrology and urology, 2018-02, Vol.7 (1), p.18-26

2018

Volltextzugriff (PDF)

Assessing a patient’s individual risk of biopsy-detectable prostate cancer: Be aware of case mix heterogeneity and a priori likelihood

European urology oncology, 2021-10, Vol.4 (5), p.813-816

2021

Volltextzugriff (PDF)

Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator

International journal of urology, 2017-12, Vol.24 (12), p.826-832

2017

Volltextzugriff (PDF)

Predicting Dropout From Organized Football: A Prospective 4-Year Study Among Adolescent and Young Adult Football Players

Frontiers in sports and active living, 2022-01, Vol.3, p.752884-752884

2022

Volltextzugriff (PDF)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy

Journal of personalized medicine, 2019-04, Vol.9 (2), p.19

2019

Volltextzugriff (PDF)

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease

Translational andrology and urology, 2018-02, Vol.7 (1), p.132-144

2018

Volltextzugriff (PDF)

MP77-13 A PROSPECTIVE EVALUATION ON THE EFFECT OF INTER-OBSERVER VARIABILITY OF DRE ON THE PERFORMANCE OF THE DRE BASED ROTTERDAM PROSTATE CANCER RISK CALCULATOR

The Journal of urology, 2017-04, Vol.197 (4), p.e1026-e1027

2017

Volltextzugriff (PDF)

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy

European urology oncology, 2018-06, Vol.1 (2), p.109-117

2018

Volltextzugriff (PDF)

MP40-04 THE IMPACT OF FALSE NEGATIVE PROSTATE SPECIFIC ANTIGEN- AND BIOPSY RESULTS IN PROSTATE CANCER SCREENING

The Journal of urology, 2018-04, Vol.199 (4), p.e520-e521

2018

Volltextzugriff (PDF)

What is an acceptable false negative rate in the detection of prostate cancer?

Translational andrology and urology, 2018-02, Vol.7 (1), p.54-60

2018

Volltextzugriff (PDF)

1 – 25 von 514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(465)
Mit Volltextzugriff
(442)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators

Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

External validation of novel magnetic resonance imaging‐based models for prostate cancer prediction

Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer

E-bike and classic bicycle-related traumatic brain injuries presenting to the emergency department

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data

Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative

Age, gender, functional KSS, reason for revision and type of bone defect predict functional outcome 5 years after revision total knee arthroplasty: a multivariable prediction model

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome

Assessing a patient’s individual risk of biopsy-detectable prostate cancer: Be aware of case mix heterogeneity and a priori likelihood

Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator

Predicting Dropout From Organized Football: A Prospective 4-Year Study Among Adolescent and Young Adult Football Players

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease

MP77-13 A PROSPECTIVE EVALUATION ON THE EFFECT OF INTER-OBSERVER VARIABILITY OF DRE ON THE PERFORMANCE OF THE DRE BASED ROTTERDAM PROSTATE CANCER RISK CALCULATOR

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy

Upscaling marine forest restoration: challenges, solutions and recommendations from the Green Gravel Action Group

MP40-04 THE IMPACT OF FALSE NEGATIVE PROSTATE SPECIFIC ANTIGEN- AND BIOPSY RESULTS IN PROSTATE CANCER SCREENING

What is an acceptable false negative rate in the detection of prostate cancer?

Suchergebnisse filtern